Next Article in Journal
Abstracts of the Constributions of the Joint Meeting on Medicinal Chemistrv June 20th to June 23rd 2005, Vienna, Austria
Previous Article in Journal
Effect of hydrophilic substances on liberation of quinidine from starch—methylcellulose spheres
Due to planned maintenance work on our platforms, there might be short service disruptions on Saturday, December 3rd, between 15:00 and 16:00 (CET).
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Synthesis and Antitumour activity of some aryl semicarbazones

by 1,*, 1, 2, 2 and 2
Department of Pharrnaceutics, Institute of Technology, Banaras Hindu University, Varanasi-221005, (INDIA)
Division of CancerTreatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, (USA)
Author to whom correspondence should be addressed.
Sci. Pharm. 2000, 68(4), 369-377;
Received: 3 May 2000 / Revised: 28 August 2000 / Accepted: 28 August 2000 / Published: 16 October 2000


Various 4-substituted phenyl semicarbazone derivatives were synthesized and evaluated in vitro by NCI in the 3-cell line, one dose primary anticancer assay. Three compounds showed significant activity against breast MCF7 cell line and were further evaluated for potential anticancer activity in an in vitro human disease-oriented tumour cell line screening panel that consisted of 60 human tumour cell lines arranged in nine subpanels, representing diverse histologies. Leukemia, colon, ovarian and breast cancer cell lines were relatively more sensitive to these compounds than the other cell lines. The 4-carboxy substituted p-nitrobenzylidene phenyl semicarbazone (1c) emerged as the most active compound with average GI50 value (the molar drug concentration required for the 50% growth inhibition) of 28.6µM. This compound showed greater activity than methotrexate against NCI-H226(Lung), BT-549 and T-47D(Breast) cancer cell lines.
Keywords: Aryl semicarbazones; Antitumour; Methotrexate Aryl semicarbazones; Antitumour; Methotrexate

Share and Cite

MDPI and ACS Style

Pandeya, S.N.; Yogeeswari, P.; Sausville, E.A.; Mauger, A.B.; Narayanan, V.L. Synthesis and Antitumour activity of some aryl semicarbazones. Sci. Pharm. 2000, 68, 369-377.

AMA Style

Pandeya SN, Yogeeswari P, Sausville EA, Mauger AB, Narayanan VL. Synthesis and Antitumour activity of some aryl semicarbazones. Scientia Pharmaceutica. 2000; 68(4):369-377.

Chicago/Turabian Style

Pandeya, S.N., P. Yogeeswari, E.A. Sausville, A.B. Mauger, and V.L. Narayanan. 2000. "Synthesis and Antitumour activity of some aryl semicarbazones" Scientia Pharmaceutica 68, no. 4: 369-377.

Article Metrics

Back to TopTop